Catalyst
Slingshot members are tracking this event:
FibroGen safety portion of roxadustat Phase 3 program in line for completion in second quarter 2017
Do you think this event is important to the companies below? How will it affect their stock price?
Related Companies | Importance
|
Impact on Stocks
|
||||
---|---|---|---|---|---|---|
FGEN | Community voting in process |
Slingshot Insights Explained
Catalyst Date
Occurred on:
Oct 31, 2017
Occurred Source:
http://investor.fibrogen.com/phoenix.zhtml?c=253783&p=irol-newsArticle&ID=2312921
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Safety Data, Roxadustat, Phase 3